behaviorceutical

— We see this commercialization as the critical final step in translating the research documenting the health-damaging effects of psychosocial risk factors and the potential of behavioral interventions to ameliorate those effects into commercial behavioral products—analogous to the pharmaceutical industry's drug products—that can be widely distributed—by a new "behaviorceutical" industry?—to prevent disease and improve the health of massesof people around the world.